SCHEMBL2284285

SCHEMBL2284285

CC1(C)CCCN(CCCOc2ccc(C3=CCN(C(=O)c4ccc(CCC(=O)OCc5ccccc5)c5ccccc45)CC3)cc2)C1

nearest known ligand 0.60

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HRH3 Q9Y5N1 2/20 0.60
HRH1 P35367 1/20 0.60
S1PR1 P21453 1/20 0.43
S1PR3 Q99500 1/20 0.43
NPC1 O15118 3/20 0.39
RAB9A P51151 3/20 0.39
KDM4E B2RXH2 3/20 0.39
SMN1; SMN2 Q16637 2/20 0.39
MAOB P27338 1/20 0.38
KCNH2 Q12809 1/20 0.38
ALDH1A1 P00352 2/20 0.37
HTT P42858 2/20 0.37
NPSR1 Q6W5P4 1/20 0.37
L3MBTL1 Q9Y468 1/20 0.37
ESR1 P03372 1/20 0.36
ITGB3 P05106 1/20 0.36
ITGA2B P08514 1/20 0.36
NPY1R P25929 1/20 0.36
PPARG P37231 2/20 0.35
PPARA Q07869 2/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4920804 0.91 HRH3 (0.72) HRH3HRH1S1PR1S1PR3MAOB
SCHEMBL3150496 0.85 HRH3 (0.48) HRH3HRH1S1PR1S1PR3NPC1
SCHEMBL3150507 0.85 HRH3 (0.48) HRH3HRH1S1PR1S1PR3NPC1
SCHEMBL3150503 0.82 HRH3 (0.51) HRH3HRH1S1PR1S1PR3NPC1
SCHEMBL12376851 0.81 GCGR (0.52) HRH3HRH1S1PR1S1PR3MAOB
SCHEMBL3150514 0.81 HRH3 (0.49) HRH3HRH1S1PR1S1PR3NPC1
SCHEMBL3158474 0.80 HRH3 (0.52) HRH3HRH1S1PR1S1PR3MAOB
SCHEMBL3158460 0.80 HRH3 (0.52) HRH3HRH1S1PR1S1PR3MAOB
SCHEMBL2283302 0.76 HRH3 (0.86) HRH3HRH1S1PR1MAOBKCNH2
SCHEMBL991736 0.76 HRH3 (1.00) HRH3HRH1S1PR1MAOBKCNH2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7989629-B2 3-(4-{ [4-(4-{ [3-(3, 3-dimethyl-1-piperidinyl) propyl] oxy} phenyl)-1-piperidinyl] carbonyl}-1-naphthalenyl) propanoic or propenoic acid as H1 and H3 receptor antagonists for the treatment of inflammatory and/or allergic disorders GLAXO GROUP LIMITED (GB) 2011-08-02 US disclosed
US-20080312280-A1 3- (4-{ [4- (4-{ [3-(3, 3-Dimethyl-1-Piperidinyl) Propyl] Oxy} Phenyl) -1-Piperidinyl] Carbonyl}-1-Naphthalenyl) Propanoic or Propenoic Acid as H1 and H3 Receptor Antagonists for the Treatment of Inflammatory and/or Allergic Disorders GLAXO GROUP LIMITED (GB) 2008-12-18 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080312280-A1 3- (4-{ [4- (4-{ [3-(3, 3-Dimethyl-1-Piperidinyl) Propyl] Oxy} Phenyl) -1-Piperidinyl] Carbonyl}-1-Naphthalenyl) Propanoic or Propenoic Acid as H1 and H3 Receptor Antagonists for the Treatment of Inflammatory and/or Allergic Disorders HRH3, HRH1, HRH2 HRH3 1/4885HRH1 2/4885S1PR1 47/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.